Lymphoblastic Leukemia Acute Adult

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-03-09
Clinical Trial Update: Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia [Phase 1, Phase 2]
Clinical trial update for CART2219.1, a dual anti-CD22/CD19 CAR-T therapy, in relapsed/refractory B-lineage leukemia, spanning Phase 1 and P…